Recent evidence indicates that glucocorticoids and catecholamines, the end-
products of the stress system, and histamine, a product of activated mast c
ells, might selectively suppress cellular immunity, and favour humoral immu
ne responses. This is mediated by a differential effect of stress hormones
and histamine, on T helper I (Th1)/Th2 patterns and type I/type 2-cytokine
production. Thus, systemically, stress might induce a Th2 shift, while, loc
ally, under certain conditions, it might induce pro-inflammatory activities
through neural activation of the peripheral corticotropin-releasing factor
-mast cell-histamine axis. Through the above mechanisms, stress may influen
ce the onset and/or course of infectious, autoimmune/ inflammatory, allergi
c and neoplastic diseases.